After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, NRIX falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Nurix Therapeutics Inc is $752.27M. A total of 0.74 million shares were traded on the day, compared to an average of 864.65K shares.
In the most recent transaction, van Houte Hans sold 5,402 shares of NRIX for 11.03 per share on Aug 01 ’25. After the transaction, the Chief Financial Officer now owns 35,512 company shares. In a previous transaction on Aug 01 ’25, JOHANNES VAN HOUTE bought 5,402 shares at 11.26 per share.
Among the insiders who sold shares, van Houte Hans disposed of 4,304 shares on Jul 30 ’25 at a per-share price of $12.01. This resulted in the Chief Financial Officer holding 40,914 shares of NRIX after the transaction. In another insider transaction, Ring Christine sold 3,841 shares at $12.01 per share on Jul 30 ’25. Company shares held by the Chief Legal Officer now total 44,009.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, NRIX has a high of $29.56 and a low of $8.18.
As of this writing, NRIX has an earnings estimate of -$0.85 per share for the current quarter. EPS was calculated based on a consensus of 15.0 estimates, with a high estimate of -$0.68 per share and a lower estimate of -$0.99. The company reported an EPS of -$0.67 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. NRIX’s latest balance sheet shows that the firm has $295.72M in Cash & Short Term Investments as of fiscal 2021. There were $13.04M in debt and $66.26M in liabilities at the time. Its Book Value Per Share was $5.86, while its Total Shareholder’s Equity was $342.30M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NRIX is Buy with a score of 4.56.
